0001209191-21-012327.txt : 20210219 0001209191-21-012327.hdr.sgml : 20210219 20210219160731 ACCESSION NUMBER: 0001209191-21-012327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210217 FILED AS OF DATE: 20210219 DATE AS OF CHANGE: 20210219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McBride Suzanne E. CENTRAL INDEX KEY: 0001767205 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33963 FILM NUMBER: 21655618 MAIL ADDRESS: STREET 1: C/O IRIDIUM COMMUNICATIONS INC. STREET 2: 1750 TYSONS BOULEVARD, SUITE 1400 CITY: MCLEAN STATE: VA ZIP: 22102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Iridium Communications Inc. CENTRAL INDEX KEY: 0001418819 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATIONS EQUIPMENT, NEC [3669] IRS NUMBER: 221344998 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1750 TYSONS BOULEVARD STREET 2: SUITE 1400 CITY: MCLEAN STATE: VA ZIP: 22102 BUSINESS PHONE: 301-571-6200 MAIL ADDRESS: STREET 1: 1750 TYSONS BOULEVARD STREET 2: SUITE 1400 CITY: MCLEAN STATE: VA ZIP: 22102 FORMER COMPANY: FORMER CONFORMED NAME: GHL Acquisition Corp. DATE OF NAME CHANGE: 20071119 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-17 0 0001418819 Iridium Communications Inc. IRDM 0001767205 McBride Suzanne E. C/O IRIDIUM COMMUNICATIONS INC. 1750 TYSONS BOULEVARD, SUITE 1400 MCLEAN VA 22102 1 1 0 0 Chief Operations Officer Common Stock 2021-02-17 4 M 0 12000 23.15 A 57602 D Common Stock 2021-02-17 4 S 0 12000 47.95 D 45602 D Employee Stock Option (Right to Buy) 23.15 2021-02-17 4 M 0 12000 0.00 D 2029-03-01 Common Stock 12000 67207 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.72 to $48.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. 25% of the shares underlying the option vested and became exercisable on March 1, 2020 and the remaining shares underlying the option vest and become exercisable quarterly thereafter in equal installments on June 1, September 1 and December 1 so that all shares of common stock underlying the option shall vest and become exercisable on March 1, 2023. /s/ Brian Leaf, Attorney-in-Fact 2021-02-19